Stocktoria
Biomea Fusion, Inc. BMEA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-04-16
Biomea Fusion, Inc. statistics & valuation
Market cap$95.4M
P / B3.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -105.5% | -173.2% | -58.6% | -63.3% | -22.4% |
| Return on equity | -209.1% | -268.4% | -69.3% | -75.4% | -23.2% |
| Current ratio | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 |
Source: SEC EDGAR filings · CIK 0001840439 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.